109620 ⎘
dsDNA viruses; Details; Adenoviridae Use of virus, viral particle or viral elements as a vector
Sub-classes:ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
#2Enhanced adoptive cell therapy
#3METHODS TO TREAT ACUTE KIDNEY INJURY WITH A FLUID
#4MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS
#5COMPOSITE NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS WITH TIME RELEASE ANTI-RESORPTIVE FACTORS
#6ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF GENETIC HEARING LOSS
#7Adeno-Associated-Virus Rep Sequences, Vectors and Viruses
#8MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#9ECTOPICALLY EXPRESSED TRANSCRIPTION FACTORS AND USES THEREOF
#10Neoantigens Expressed In Ovarian Cancer And Their Uses
#11GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT
#12SARS-COV-2 MULTI-EPITOPE VACCINES
#13METHODS AND COMPOSITIONS FOR ACCELERATING OLIGODENDROCYTE MATURATION
#14VECTOR, LINEAR COVALENTLY CLOSED DNA PRODUCTION METHOD USING VECTOR, PARVOVIRUS VECTOR PRODUCTION METHOD, AND PARVOVIRUS-VECTOR-PRODUCING CELL PRODUCTION METHOD
#15Oncolytic Virus and Methods of Use
#16LYSOSOMAL ACID LIPASE VARIANTS AND USES THEREOF
#17Adenoviral vector not including replication competent adenovirus, and use thereof
#18TROPHIN GENOME EDITING FOR TREATING DUCHENNE MUSCULAR DYSTROPHY (DMD)
#19NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN PANCREATIC TROPISM
#20PRODUCTION SYSTEM FOR HELPER-DEPENDENT ADENOVIRUS
#21CELLULAR REPROGRAMMING OF HUMAN ADIPOCYTES
#22ALL-IN-ONE AAV VECTORS FOR TREATING CORONAVIRUS-INDUCED DISEASES
#23ENHANCEMENT OF THE PRODUCTION OF ADENOIDVIRUS-BASED GENETRANSFER VECTORS
#24COMPOSITIONS AND METHODS FOR TREATMENT OF GENE THERAPY PATIENTS
#25USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS
#26METHODS AND COMPOSITIONS FOR VIRAL VECTORED GnRH VACCINES TO CONTROL REPRODUCTION AND BREEDING BEHAVIOR IN MAMMALS
#27Non-human animals comprising a humanized TTR locus and methods of use
#28DNA Amplification Method
#29OPTOGENETIC COMPOSITIONS COMPRISING A CBh PROMOTER SEQUENCE AND METHODS FOR USE
#30Hydrodynamic Methods for Delivering Fluids to Kidney Tissues and Related Materials and Methods
#31Vaccine against RSV
#32USE OF ION CONCENTRATIONS TO INCREASE THE PACKAGING EFFICIENCY OF RECOMBINANT ADENO-ASSOCIATED VIRUS
#33AAV MUTANT HAVING BRAIN-TARGETING PROPERTY
#34COMBINATION IMMUNOTHERAPY
#35Methods and compositions for inducing protective immunity against filovirus infection
#36IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODUCTION AND USE THEREOF FOR TREATMENT OF CANCER
#37Neoantigens expressed in ovarian cancer and their uses
#38MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#39Multimodal Vector for Dendritic Cell Infection
#40Adeno-associated virus (AAV) systems for treatment of genetic hearing loss
#41ENGINEERED VEGF VARIANTS FOR RETINAL NEUROPROTECTION, PROMOTION OF AXON GROWTH AND AXON REGENERATION
#42Optimised coding sequence and promoter
#43Enhanced adoptive cell therapy
#44Vaccine against RSV
#45TREATMENT OF EYE DISEASE
#46GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT
#47Therapeutic HPV16 vaccines
#48Method for removing anti-AAV antibodies from a blood-derived composition
#49Methods and compositions for inducing protective immunity against filovirus infection
#50Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism
#51Adenoviral vector system for gene delivery
#52Adeno-associated-virus Rep sequences, vectors and viruses
#53TREATMENT OF EYE DISEASE
#54Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer
#55Vaccine against RSV
#56Method for promoting muscle regeneration
#57Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use
#58Group B adenovirus encoding an anti-TCR-complex antibody or fragment
#59Production of oversized adeno-associated vectors
#60Virus encoding an anti-TCR-complex antibody or fragment
#61TREATMENT OF EYE DISEASE
#62Therapeutic HPV16 vaccines
#63Methods and compositions for combination immunotherapy
#64Ebola virus disease vaccine taking human replication deficient adenovirus as vector
#65METHODS AND COMPOSITIONS FOR ENHANCING GENE EDITING
#66Combination immunotherapy
#67Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#68Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#69Canine adenovirus vectors
#70TREATMENT OF EYE DISEASE
#71COMPOSITION AND USES THEREOF
#72Optimised coding sequence and promoter
#73Methods and compositions for inducing protective immunity against filovirus infection
#74Therapeutic HPV16 vaccines
#75METHODS FOR TREATING TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA WITH APOLIPOPROTEIN D
#76Enhanced adoptive cell therapy
#77Methods for determining modulators of insect transient receptor potential V (TRPV) channel
#78Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods
#79Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#80Materials and methods for the treatment of pathological neovascularization in the eye
#81Composition and uses thereof
#82Delivery of a therapeutic agent to the cerebral cortex by administering a viral vector by convection enhanced diffusion into the white matter of the brain
#83Therapeutic HPV16 vaccines
#84Gene therapy composition for use in diabetes treatment
#85Adeno-associated-virus Rep sequences, vectors and viruses
#86Methods for treating tissue damage associated with ischemia with apolipoprotein D
#87TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS
#88Optimised coding sequence and promoter
#89Enhanced adoptive cell therapy
#90Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#91Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
#92Pharmaceutical Composition and Method for the Treatment of Neurodegenerative Diseases, in Particular Amyotrophic Lateral Sclerosis
#93Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
#94COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY
#95Complementing cell lines
#96INFLUENZA VACCINES CONTAINING MODIFIED ADENOVIRUS VECTORS
#97Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#98MODIFIED ADENOVIRAL VECTORS AND METHODS OF TREATMENT USING SAME
#99Gene therapy composition for use in diabetes treatment
#100Immune suppressor and its use
#101Mutant CD83 promoter and use thereof
#102Optimised coding sequence and promoter
#103Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#104Materials and methods for the treatment of pathological neovascularization in the eye
#105Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#106Treatment of cellular proliferative disorders
#107Complementing cell lines
#108Complementing cell lines
#109Drug delivery to the inner ear and methods of using same
#110Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus
#111TAA/ecdCD40L oncolytic virus